WIN Symposium 2015 highlights
WIN Symposium 2015 highlights
Next generation of trials with targeted agents
Taking biopsies in clinical trials: The WINTHER laboratory experience
Meta-analysis confirms benefits and safety of precision medicine
SPECTAlung: improving clinical trial access for patients with thoracic tumours
Chemoresistance and residual disease promoted by DNMT3A R882 in AML
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Exciting update on the Repurposing Drugs in Oncology (ReDO) project
EHA 2015: Expert opinions on new treatment standard in multiple myeloma
Genomic sequencing to find AML-causing mutations
Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia
Advances in the treatment and management of CLL